What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001965304
Total reported value
$108.2M
$108.2M
28 檔
46.5%
During the Q4 2024 filing period, Michelson Medical Research Foundation, Inc. (CIK: 0001965304) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $108.2M across 28 reported positions.
In Q4 2024, Michelson Medical Research Foundation, Inc. adopted a defensive or profit-taking posture, trimming 7 positions and completely liquidating 1 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MTN | Vail Resorts Inc | Stock-Consumer Disc | 13.51% | -11.20% | EXIT | |
| 2 | IVE | Ishares S&p 500 Value ETF | ETF-Large Cap & Growth | 8.30% | -0.24% | — | |
| 3 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 7.40% | — | — | |
| 4 | GDX | Vaneck Gold Miners ETF | ETF-Commodities | 6.66% | — | — | |
| 5 | VEA | Vanguard Ftse Developed ETF | ETF-Other | 6.34% | +0.12% | -56.21% | |
| 6 | CMP | Compass Minerals Internation | Stock-Other | 5.66% | — | +18.81% | |
| 7 | EL | Estee Lauder Companies-cl A | Stock-Consumer Staples | 5.03% | — | — | |
| 8 | IBB | Ishares Biotechnology ETF | ETF-Tech | 4.81% | +0.15% | — | |
| 9 | VWO | Vanguard Ftse Emerging Marke | ETF-Emerging Markets | 4.71% | +0.04% | -46.06% | |
| 10 | KRE | Ss Spdr S&p Regional Bank | ETF-Other | 3.90% | +0.19% | -32.78% | |
| 11 | IWC | Ishares Micro-cap ETF | ETF-Other | 3.87% | +0.81% | — | |
| 12 | RTO | Rentokil Initial Plc-sp Adr | Stock-Other | 3.82% | — | — | |
| 13 | ARE | Alexandria Real Estate Equit | Stock-Real Estate | 3.04% | — | — | |
| 14 | PLD | Prologis Inc | Stock-Real Estate | 2.49% | — | -33.79% | |
| 15 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 2.36% | — | — | |
| 16 | VB | Vanguard Small-cap ETF | ETF-Other | 2.22% | +0.15% | -41.78% | |
| 17 | SUI | Sun Communities Inc | Stock-Real Estate | 2.06% | — | -60.00% | |
| 18 | BUR | Burford Capital Limited | Stock-Other | 1.92% | — | — | |
| 19 | CRGY | Crescent Energy Inc-a | Stock-Energy | 1.91% | -0.72% | — | |
| 20 | EWW | Ishares Msci Mexico ETF | ETF-Other | 1.64% | -0.29% | — | |
| 21 | EWZ | Ishares Msci Brazil ETF | ETF-Other | 1.53% | -0.58% | — | |
| 22 | BXP | Bxp Inc | Stock-Real Estate | 1.35% | — | — | |
| 23 | EWT | Ishares Msci Taiwan ETF | ETF-Other | 1.19% | +0.77% | — | |
| 24 | EWJ | Ishares Msci Japan ETF | ETF-Other | 1.13% | +0.01% | — | |
| 25 | GXC | State Street Spdr S&p China | ETF-Emerging Markets | 1.07% | -0.24% | — | |
| 26 | EWY | Ishares Msci South Korea ETF | ETF-Other | 0.86% | +1.24% | — | |
| 27 | NML | Neuberger Energy Infrastruct | Stock-Other | 0.86% | — | — | |
| 28 | AVB | Avalonbay Communities Inc | Stock-Real Estate | 0.36% | — | -88.08% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MTN | Vail Resorts Inc | +7.4% | +72.00% | Add |
| 2 | EL | Estee Lauder Companies-cl A | +5% | NEW | New buy |
| 3 | CMP | Compass Minerals Internation | +1.4% | +18.81% | Add |
| 4 | IVV | Ishares Core S&p 500 ETF | +1.3% | — | Unchanged |
| 5 | IVE | Ishares S&p 500 Value ETF | +1.1% | — | Unchanged |
| 6 | IWC | Ishares Micro-cap ETF | +0.8% | — | Unchanged |
| 7 | CRGY | Crescent Energy Inc-a | +0.7% | — | Unchanged |
| 8 | RTO | Rentokil Initial Plc-sp Adr | +0.7% | — | Unchanged |
| 9 | IBB | Ishares Biotechnology ETF | +0.4% | — | Unchanged |
| 10 | BUR | Burford Capital Limited | +0.2% | — | Unchanged |
| 11 | NML | Neuberger Energy Infrastruct | +0.2% | — | Unchanged |
| 12 | XBI | Ss Spdr S&p Biotech ETF | +0.2% | — | Unchanged |
| 13 | EWT | Ishares Msci Taiwan ETF | +0.2% | — | Unchanged |
| 14 | BXP | Bxp Inc | +0.1% | — | Unchanged |
| 15 | EWJ | Ishares Msci Japan ETF | +0.1% | — | Unchanged |
| 16 | GXC | State Street Spdr S&p China | +0.1% | — | Unchanged |
| 17 | GDX | Vaneck Gold Miners ETF | +0.1% | — | Unchanged |
| 18 | EWW | Ishares Msci Mexico ETF | +0.1% | — | Unchanged |
| 19 | EWY | Ishares Msci South Korea ETF | -0.1% | — | Unchanged |
| 20 | ARE | Alexandria Real Estate Equit | -0.1% | — | Unchanged |
| 21 | EWZ | Ishares Msci Brazil ETF | -0.2% | — | Unchanged |
| 22 | KRE | Ss Spdr S&p Regional Bank | -0.7% | -32.78% | Trim |
| 23 | VB | Vanguard Small-cap ETF | -0.9% | -41.78% | Trim |
| 24 | PLD | Prologis Inc | -1.3% | -33.79% | Trim |
| 25 | EPAM | Epam Systems Inc | -1.4% | EXIT | Sold out |
| 26 | AVB | Avalonbay Communities Inc | -2.2% | -88.08% | Trim |
| 27 | SUI | Sun Communities Inc | -2.7% | -60.00% | Trim |
| 28 | VWO | Vanguard Ftse Emerging Marke | -3.3% | -46.06% | Trim |
| 29 | VEA | Vanguard Ftse Developed ETF | -7.1% | -56.21% | Trim |
According to official SEC Form 13F filings, Michelson Medical Research Foundation, Inc. reported a total U.S. public equity portfolio value of $108.2M across 28 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including MTN, IVE, IVV) accounted for 46.5% of total reported equity market value during Q4 2024.
Top New Position Initiated
EL
市值: $6.0M
Top Position Liquidated / Trimmed
EPAM
前期市值: $2.0M
During Q4 2024, Michelson Medical Research Foundation, Inc.'s top holdings by market value included MTN (13.5%)、IVE (8.3%)、IVV (7.4%). The largest single position, MTN, represented 13.5% of total portfolio value.
In Q4 2024, Michelson Medical Research Foundation, Inc. made 11 total portfolio adjustments, initiating 1 new buys, adding to 2 positions, trimming 7 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.